We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 143

Delhi High Court upholds foreign award in favour of daiichi (except qua minor respondents)
  • Khaitan & Co
  • Singapore, India
  • February 6 2018

By a judgment delivered on 31 January 2018, the Delhi High Court has held that the award passed in favour of Daiichi Sankyo Company Ltd. (the

Clinical trials lawyer welcomes FDA programme on Indian clinical trials
  • Leigh Day
  • India
  • July 14 2017

Clinical trials lawyer Gene Matthews has welcomed a push from the Federal Drug Agency (FDA) to promote safety and quality in clinical trials that are

Dietary Supplement & Cosmetics Legal Bulletin: January 2017
  • Shook Hardy & Bacon LLP
  • USA, India
  • January 19 2017

In December, the U.S. Food and Drug Administration (FDA) announced that it will make publicly available certain data received through the Center for

Ranbaxy loses FDA approval for two generics
  • Shook Hardy & Bacon LLP
  • USA, India
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA)

India's new biosimilar guidelines and their relationship to the rest of the world
  • Dechert LLP
  • India
  • July 16 2012

The Indian Ministries of Health & Family Welfare and Science and Technology have released their Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India (the “Indian Guidelines”).

Indian state seizes Red Bull, caffeine content above legal limits
  • Shook Hardy & Bacon LLP
  • India
  • April 6 2012

The Maharashtra Food and Drug Administration (MFDA) has reportedly seized more than 1 million cans of Red Bull, an energy drink containing 250-300 parts per million (ppm) of caffeine, on the ground that the product exceeds the 145 ppm limit for carbonated beverages.